The content of this press release is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

CONTACT: NeoStem         Dr. Robin L. Smith         Chairman and CEO         Phone: +1-212-584-4174         Email: rsmith@neostem.com

NeoStem Inc. Logo

If you liked this article you might like

Neostem (NBS) Stock Declines After Pricing Secondary Public Offering

3 Breakout Stocks Under $10 for Your Trading Radar

Insider Trading Alert - UGI, NBS And MACK Traded By Insiders

Neostem (NBS): Today's Weak On High Volume Stock

NeoStem (NBS) Stock Plummets Today on Disappointing Cardiac Stem-Cell Therapy Data